Medical Care

Global Clinical Whole Exome Sequencing (WES) Market Research Report 2025

The global market for Clinical Whole Exome Sequencing (WES) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Clinical Whole Exome Sequencing (WES) is a comprehensive genetic test that identifies changes in a patient"s DNA that cause or are related to their medical problems. By focusing on the entire protein-coding region of the genome (the exome), it provides the coverage needed to diagnose patients quickly and reliably.
North American market for Clinical Whole Exome Sequencing (WES) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Clinical Whole Exome Sequencing (WES) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Clinical Whole Exome Sequencing (WES) in Rare Genetic Disease is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Clinical Whole Exome Sequencing (WES) include CentoXome, Mayo Clinic Laboratories, Baylor Genetics, Blueprint Genetics, GeneDx, CD Genomics, Illumina, Thermo Fisher, Labassure, Yale Medicine, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Clinical Whole Exome Sequencing (WES), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Whole Exome Sequencing (WES).
The Clinical Whole Exome Sequencing (WES) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Whole Exome Sequencing (WES) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Whole Exome Sequencing (WES) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CentoXome
Mayo Clinic Laboratories
Baylor Genetics
Blueprint Genetics
GeneDx
CD Genomics
Illumina
Thermo Fisher
Labassure
Yale Medicine
Genosalut
Caris Life Sciences
InterGenetics
Genomics and Pathology Services (GPS)
3billion
Broad Genomic
Roche
Novogene
BGI Genomics
Shanghai Jingzhou Genomics
Shihe Gene Biotechnology
JUNO Genomics
Segment by Type
Array-Based Exome Enrichment
Enrichment of the Exome in Solution using Biotinylated Probes
Segment by Application
Rare Genetic Disease
Genetic Testing Unsuccessful
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Whole Exome Sequencing (WES) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Array-Based Exome Enrichment
1.2.3 Enrichment of the Exome in Solution using Biotinylated Probes
1.3 Market by Application
1.3.1 Global Clinical Whole Exome Sequencing (WES) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Rare Genetic Disease
1.3.3 Genetic Testing Unsuccessful
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Whole Exome Sequencing (WES) Market Perspective (2020-2031)
2.2 Global Clinical Whole Exome Sequencing (WES) Growth Trends by Region
2.2.1 Global Clinical Whole Exome Sequencing (WES) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Whole Exome Sequencing (WES) Historic Market Size by Region (2020-2025)
2.2.3 Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Region (2026-2031)
2.3 Clinical Whole Exome Sequencing (WES) Market Dynamics
2.3.1 Clinical Whole Exome Sequencing (WES) Industry Trends
2.3.2 Clinical Whole Exome Sequencing (WES) Market Drivers
2.3.3 Clinical Whole Exome Sequencing (WES) Market Challenges
2.3.4 Clinical Whole Exome Sequencing (WES) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Whole Exome Sequencing (WES) Players by Revenue
3.1.1 Global Top Clinical Whole Exome Sequencing (WES) Players by Revenue (2020-2025)
3.1.2 Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Players (2020-2025)
3.2 Global Clinical Whole Exome Sequencing (WES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Whole Exome Sequencing (WES) Revenue
3.4 Global Clinical Whole Exome Sequencing (WES) Market Concentration Ratio
3.4.1 Global Clinical Whole Exome Sequencing (WES) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Whole Exome Sequencing (WES) Revenue in 2024
3.5 Global Key Players of Clinical Whole Exome Sequencing (WES) Head office and Area Served
3.6 Global Key Players of Clinical Whole Exome Sequencing (WES), Product and Application
3.7 Global Key Players of Clinical Whole Exome Sequencing (WES), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Whole Exome Sequencing (WES) Breakdown Data by Type
4.1 Global Clinical Whole Exome Sequencing (WES) Historic Market Size by Type (2020-2025)
4.2 Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Type (2026-2031)
5 Clinical Whole Exome Sequencing (WES) Breakdown Data by Application
5.1 Global Clinical Whole Exome Sequencing (WES) Historic Market Size by Application (2020-2025)
5.2 Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Whole Exome Sequencing (WES) Market Size (2020-2031)
6.2 North America Clinical Whole Exome Sequencing (WES) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Clinical Whole Exome Sequencing (WES) Market Size by Country (2020-2025)
6.4 North America Clinical Whole Exome Sequencing (WES) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Whole Exome Sequencing (WES) Market Size (2020-2031)
7.2 Europe Clinical Whole Exome Sequencing (WES) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Clinical Whole Exome Sequencing (WES) Market Size by Country (2020-2025)
7.4 Europe Clinical Whole Exome Sequencing (WES) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size (2020-2031)
8.2 Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size by Region (2020-2025)
8.4 Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Whole Exome Sequencing (WES) Market Size (2020-2031)
9.2 Latin America Clinical Whole Exome Sequencing (WES) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country (2020-2025)
9.4 Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size (2020-2031)
10.2 Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size by Country (2020-2025)
10.4 Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CentoXome
11.1.1 CentoXome Company Details
11.1.2 CentoXome Business Overview
11.1.3 CentoXome Clinical Whole Exome Sequencing (WES) Introduction
11.1.4 CentoXome Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.1.5 CentoXome Recent Development
11.2 Mayo Clinic Laboratories
11.2.1 Mayo Clinic Laboratories Company Details
11.2.2 Mayo Clinic Laboratories Business Overview
11.2.3 Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Introduction
11.2.4 Mayo Clinic Laboratories Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.2.5 Mayo Clinic Laboratories Recent Development
11.3 Baylor Genetics
11.3.1 Baylor Genetics Company Details
11.3.2 Baylor Genetics Business Overview
11.3.3 Baylor Genetics Clinical Whole Exome Sequencing (WES) Introduction
11.3.4 Baylor Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.3.5 Baylor Genetics Recent Development
11.4 Blueprint Genetics
11.4.1 Blueprint Genetics Company Details
11.4.2 Blueprint Genetics Business Overview
11.4.3 Blueprint Genetics Clinical Whole Exome Sequencing (WES) Introduction
11.4.4 Blueprint Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.4.5 Blueprint Genetics Recent Development
11.5 GeneDx
11.5.1 GeneDx Company Details
11.5.2 GeneDx Business Overview
11.5.3 GeneDx Clinical Whole Exome Sequencing (WES) Introduction
11.5.4 GeneDx Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.5.5 GeneDx Recent Development
11.6 CD Genomics
11.6.1 CD Genomics Company Details
11.6.2 CD Genomics Business Overview
11.6.3 CD Genomics Clinical Whole Exome Sequencing (WES) Introduction
11.6.4 CD Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.6.5 CD Genomics Recent Development
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Clinical Whole Exome Sequencing (WES) Introduction
11.7.4 Illumina Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.7.5 Illumina Recent Development
11.8 Thermo Fisher
11.8.1 Thermo Fisher Company Details
11.8.2 Thermo Fisher Business Overview
11.8.3 Thermo Fisher Clinical Whole Exome Sequencing (WES) Introduction
11.8.4 Thermo Fisher Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.8.5 Thermo Fisher Recent Development
11.9 Labassure
11.9.1 Labassure Company Details
11.9.2 Labassure Business Overview
11.9.3 Labassure Clinical Whole Exome Sequencing (WES) Introduction
11.9.4 Labassure Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.9.5 Labassure Recent Development
11.10 Yale Medicine
11.10.1 Yale Medicine Company Details
11.10.2 Yale Medicine Business Overview
11.10.3 Yale Medicine Clinical Whole Exome Sequencing (WES) Introduction
11.10.4 Yale Medicine Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.10.5 Yale Medicine Recent Development
11.11 Genosalut
11.11.1 Genosalut Company Details
11.11.2 Genosalut Business Overview
11.11.3 Genosalut Clinical Whole Exome Sequencing (WES) Introduction
11.11.4 Genosalut Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.11.5 Genosalut Recent Development
11.12 Caris Life Sciences
11.12.1 Caris Life Sciences Company Details
11.12.2 Caris Life Sciences Business Overview
11.12.3 Caris Life Sciences Clinical Whole Exome Sequencing (WES) Introduction
11.12.4 Caris Life Sciences Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.12.5 Caris Life Sciences Recent Development
11.13 InterGenetics
11.13.1 InterGenetics Company Details
11.13.2 InterGenetics Business Overview
11.13.3 InterGenetics Clinical Whole Exome Sequencing (WES) Introduction
11.13.4 InterGenetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.13.5 InterGenetics Recent Development
11.14 Genomics and Pathology Services (GPS)
11.14.1 Genomics and Pathology Services (GPS) Company Details
11.14.2 Genomics and Pathology Services (GPS) Business Overview
11.14.3 Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Introduction
11.14.4 Genomics and Pathology Services (GPS) Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.14.5 Genomics and Pathology Services (GPS) Recent Development
11.15 3billion
11.15.1 3billion Company Details
11.15.2 3billion Business Overview
11.15.3 3billion Clinical Whole Exome Sequencing (WES) Introduction
11.15.4 3billion Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.15.5 3billion Recent Development
11.16 Broad Genomic
11.16.1 Broad Genomic Company Details
11.16.2 Broad Genomic Business Overview
11.16.3 Broad Genomic Clinical Whole Exome Sequencing (WES) Introduction
11.16.4 Broad Genomic Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.16.5 Broad Genomic Recent Development
11.17 Roche
11.17.1 Roche Company Details
11.17.2 Roche Business Overview
11.17.3 Roche Clinical Whole Exome Sequencing (WES) Introduction
11.17.4 Roche Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.17.5 Roche Recent Development
11.18 Novogene
11.18.1 Novogene Company Details
11.18.2 Novogene Business Overview
11.18.3 Novogene Clinical Whole Exome Sequencing (WES) Introduction
11.18.4 Novogene Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.18.5 Novogene Recent Development
11.19 BGI Genomics
11.19.1 BGI Genomics Company Details
11.19.2 BGI Genomics Business Overview
11.19.3 BGI Genomics Clinical Whole Exome Sequencing (WES) Introduction
11.19.4 BGI Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.19.5 BGI Genomics Recent Development
11.20 Shanghai Jingzhou Genomics
11.20.1 Shanghai Jingzhou Genomics Company Details
11.20.2 Shanghai Jingzhou Genomics Business Overview
11.20.3 Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Introduction
11.20.4 Shanghai Jingzhou Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.20.5 Shanghai Jingzhou Genomics Recent Development
11.21 Shihe Gene Biotechnology
11.21.1 Shihe Gene Biotechnology Company Details
11.21.2 Shihe Gene Biotechnology Business Overview
11.21.3 Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Introduction
11.21.4 Shihe Gene Biotechnology Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.21.5 Shihe Gene Biotechnology Recent Development
11.22 JUNO Genomics
11.22.1 JUNO Genomics Company Details
11.22.2 JUNO Genomics Business Overview
11.22.3 JUNO Genomics Clinical Whole Exome Sequencing (WES) Introduction
11.22.4 JUNO Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
11.22.5 JUNO Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Array-Based Exome Enrichment
Table 3. Key Players of Enrichment of the Exome in Solution using Biotinylated Probes
Table 4. Global Clinical Whole Exome Sequencing (WES) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Clinical Whole Exome Sequencing (WES) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Clinical Whole Exome Sequencing (WES) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Clinical Whole Exome Sequencing (WES) Market Share by Region (2020-2025)
Table 8. Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Clinical Whole Exome Sequencing (WES) Market Share by Region (2026-2031)
Table 10. Clinical Whole Exome Sequencing (WES) Market Trends
Table 11. Clinical Whole Exome Sequencing (WES) Market Drivers
Table 12. Clinical Whole Exome Sequencing (WES) Market Challenges
Table 13. Clinical Whole Exome Sequencing (WES) Market Restraints
Table 14. Global Clinical Whole Exome Sequencing (WES) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Clinical Whole Exome Sequencing (WES) Market Share by Players (2020-2025)
Table 16. Global Top Clinical Whole Exome Sequencing (WES) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Whole Exome Sequencing (WES) as of 2024)
Table 17. Ranking of Global Top Clinical Whole Exome Sequencing (WES) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Clinical Whole Exome Sequencing (WES) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Clinical Whole Exome Sequencing (WES), Headquarters and Area Served
Table 20. Global Key Players of Clinical Whole Exome Sequencing (WES), Product and Application
Table 21. Global Key Players of Clinical Whole Exome Sequencing (WES), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Clinical Whole Exome Sequencing (WES) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Type (2020-2025)
Table 25. Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Type (2026-2031)
Table 27. Global Clinical Whole Exome Sequencing (WES) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Application (2020-2025)
Table 29. Global Clinical Whole Exome Sequencing (WES) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Clinical Whole Exome Sequencing (WES) Revenue Market Share by Application (2026-2031)
Table 31. North America Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Clinical Whole Exome Sequencing (WES) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Clinical Whole Exome Sequencing (WES) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Clinical Whole Exome Sequencing (WES) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Clinical Whole Exome Sequencing (WES) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Clinical Whole Exome Sequencing (WES) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size by Country (2026-2031) & (US$ Million)
Table 46. CentoXome Company Details
Table 47. CentoXome Business Overview
Table 48. CentoXome Clinical Whole Exome Sequencing (WES) Product
Table 49. CentoXome Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 50. CentoXome Recent Development
Table 51. Mayo Clinic Laboratories Company Details
Table 52. Mayo Clinic Laboratories Business Overview
Table 53. Mayo Clinic Laboratories Clinical Whole Exome Sequencing (WES) Product
Table 54. Mayo Clinic Laboratories Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 55. Mayo Clinic Laboratories Recent Development
Table 56. Baylor Genetics Company Details
Table 57. Baylor Genetics Business Overview
Table 58. Baylor Genetics Clinical Whole Exome Sequencing (WES) Product
Table 59. Baylor Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 60. Baylor Genetics Recent Development
Table 61. Blueprint Genetics Company Details
Table 62. Blueprint Genetics Business Overview
Table 63. Blueprint Genetics Clinical Whole Exome Sequencing (WES) Product
Table 64. Blueprint Genetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 65. Blueprint Genetics Recent Development
Table 66. GeneDx Company Details
Table 67. GeneDx Business Overview
Table 68. GeneDx Clinical Whole Exome Sequencing (WES) Product
Table 69. GeneDx Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 70. GeneDx Recent Development
Table 71. CD Genomics Company Details
Table 72. CD Genomics Business Overview
Table 73. CD Genomics Clinical Whole Exome Sequencing (WES) Product
Table 74. CD Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 75. CD Genomics Recent Development
Table 76. Illumina Company Details
Table 77. Illumina Business Overview
Table 78. Illumina Clinical Whole Exome Sequencing (WES) Product
Table 79. Illumina Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 80. Illumina Recent Development
Table 81. Thermo Fisher Company Details
Table 82. Thermo Fisher Business Overview
Table 83. Thermo Fisher Clinical Whole Exome Sequencing (WES) Product
Table 84. Thermo Fisher Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 85. Thermo Fisher Recent Development
Table 86. Labassure Company Details
Table 87. Labassure Business Overview
Table 88. Labassure Clinical Whole Exome Sequencing (WES) Product
Table 89. Labassure Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 90. Labassure Recent Development
Table 91. Yale Medicine Company Details
Table 92. Yale Medicine Business Overview
Table 93. Yale Medicine Clinical Whole Exome Sequencing (WES) Product
Table 94. Yale Medicine Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 95. Yale Medicine Recent Development
Table 96. Genosalut Company Details
Table 97. Genosalut Business Overview
Table 98. Genosalut Clinical Whole Exome Sequencing (WES) Product
Table 99. Genosalut Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 100. Genosalut Recent Development
Table 101. Caris Life Sciences Company Details
Table 102. Caris Life Sciences Business Overview
Table 103. Caris Life Sciences Clinical Whole Exome Sequencing (WES) Product
Table 104. Caris Life Sciences Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 105. Caris Life Sciences Recent Development
Table 106. InterGenetics Company Details
Table 107. InterGenetics Business Overview
Table 108. InterGenetics Clinical Whole Exome Sequencing (WES) Product
Table 109. InterGenetics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 110. InterGenetics Recent Development
Table 111. Genomics and Pathology Services (GPS) Company Details
Table 112. Genomics and Pathology Services (GPS) Business Overview
Table 113. Genomics and Pathology Services (GPS) Clinical Whole Exome Sequencing (WES) Product
Table 114. Genomics and Pathology Services (GPS) Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 115. Genomics and Pathology Services (GPS) Recent Development
Table 116. 3billion Company Details
Table 117. 3billion Business Overview
Table 118. 3billion Clinical Whole Exome Sequencing (WES) Product
Table 119. 3billion Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 120. 3billion Recent Development
Table 121. Broad Genomic Company Details
Table 122. Broad Genomic Business Overview
Table 123. Broad Genomic Clinical Whole Exome Sequencing (WES) Product
Table 124. Broad Genomic Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 125. Broad Genomic Recent Development
Table 126. Roche Company Details
Table 127. Roche Business Overview
Table 128. Roche Clinical Whole Exome Sequencing (WES) Product
Table 129. Roche Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 130. Roche Recent Development
Table 131. Novogene Company Details
Table 132. Novogene Business Overview
Table 133. Novogene Clinical Whole Exome Sequencing (WES) Product
Table 134. Novogene Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 135. Novogene Recent Development
Table 136. BGI Genomics Company Details
Table 137. BGI Genomics Business Overview
Table 138. BGI Genomics Clinical Whole Exome Sequencing (WES) Product
Table 139. BGI Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 140. BGI Genomics Recent Development
Table 141. Shanghai Jingzhou Genomics Company Details
Table 142. Shanghai Jingzhou Genomics Business Overview
Table 143. Shanghai Jingzhou Genomics Clinical Whole Exome Sequencing (WES) Product
Table 144. Shanghai Jingzhou Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 145. Shanghai Jingzhou Genomics Recent Development
Table 146. Shihe Gene Biotechnology Company Details
Table 147. Shihe Gene Biotechnology Business Overview
Table 148. Shihe Gene Biotechnology Clinical Whole Exome Sequencing (WES) Product
Table 149. Shihe Gene Biotechnology Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 150. Shihe Gene Biotechnology Recent Development
Table 151. JUNO Genomics Company Details
Table 152. JUNO Genomics Business Overview
Table 153. JUNO Genomics Clinical Whole Exome Sequencing (WES) Product
Table 154. JUNO Genomics Revenue in Clinical Whole Exome Sequencing (WES) Business (2020-2025) & (US$ Million)
Table 155. JUNO Genomics Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report


List of Figures
Figure 1. Clinical Whole Exome Sequencing (WES) Picture
Figure 2. Global Clinical Whole Exome Sequencing (WES) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Clinical Whole Exome Sequencing (WES) Market Share by Type: 2024 VS 2031
Figure 4. Array-Based Exome Enrichment Features
Figure 5. Enrichment of the Exome in Solution using Biotinylated Probes Features
Figure 6. Global Clinical Whole Exome Sequencing (WES) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Clinical Whole Exome Sequencing (WES) Market Share by Application: 2024 VS 2031
Figure 8. Rare Genetic Disease Case Studies
Figure 9. Genetic Testing Unsuccessful Case Studies
Figure 10. Others Case Studies
Figure 11. Clinical Whole Exome Sequencing (WES) Report Years Considered
Figure 12. Global Clinical Whole Exome Sequencing (WES) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Clinical Whole Exome Sequencing (WES) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Clinical Whole Exome Sequencing (WES) Market Share by Region: 2024 VS 2031
Figure 15. Global Clinical Whole Exome Sequencing (WES) Market Share by Players in 2024
Figure 16. Global Top Clinical Whole Exome Sequencing (WES) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Whole Exome Sequencing (WES) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Clinical Whole Exome Sequencing (WES) Revenue in 2024
Figure 18. North America Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Clinical Whole Exome Sequencing (WES) Market Share by Country (2020-2031)
Figure 20. United States Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Clinical Whole Exome Sequencing (WES) Market Share by Country (2020-2031)
Figure 24. Germany Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Clinical Whole Exome Sequencing (WES) Market Share by Region (2020-2031)
Figure 32. China Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Clinical Whole Exome Sequencing (WES) Market Share by Country (2020-2031)
Figure 40. Mexico Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Clinical Whole Exome Sequencing (WES) Market Share by Country (2020-2031)
Figure 44. Turkey Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Clinical Whole Exome Sequencing (WES) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. CentoXome Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 48. Mayo Clinic Laboratories Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 49. Baylor Genetics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 50. Blueprint Genetics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 51. GeneDx Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 52. CD Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 53. Illumina Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 54. Thermo Fisher Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 55. Labassure Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 56. Yale Medicine Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 57. Genosalut Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 58. Caris Life Sciences Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 59. InterGenetics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 60. Genomics and Pathology Services (GPS) Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 61. 3billion Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 62. Broad Genomic Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 63. Roche Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 64. Novogene Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 65. BGI Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 66. Shanghai Jingzhou Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 67. Shihe Gene Biotechnology Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 68. JUNO Genomics Revenue Growth Rate in Clinical Whole Exome Sequencing (WES) Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies